United Kingdom vs Zambia: Access to anti-retroviral drugs, female
United Kingdom
96.0%
in 2023
Zambia
96.0%
in 2024
United Kingdom rank
14th
Zambia rank
14th
Access to anti-retroviral drugs, female over time
- United Kingdom
- Zambia
How they compare
United Kingdom currently reports 96.0% against 96.0% in Zambia, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2016 it was United Kingdom ahead.
United Kingdom ranks 14th and Zambia ranks 14th of 141 countries.
Across the 2 decades both report, United Kingdom averaged higher in 1 and Zambia in 1.
Head to head by decade
| Decade | United Kingdom | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.0% | 74.0% | 14.0% | United Kingdom |
| 2020s | 90.8% | 91.5% | 0.8% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, United Kingdom or Zambia?
- United Kingdom, at 96.0% against 96.0% in Zambia as of 2023.
- What is the difference in access to anti-retroviral drugs, female between United Kingdom and Zambia?
- 0.0%, with United Kingdom ahead.
- How many years of comparable data are there for United Kingdom and Zambia?
- 8 years are reported by both, from 2016 to 2023.
- How do United Kingdom and Zambia rank globally for access to anti-retroviral drugs, female?
- United Kingdom ranks 14th and Zambia ranks 14th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.